Robert Englert is a Medical Device and Life Sciences executive with 25 years of global experience in IVD, Point of Care and digital health. Previously Bob was CEO and Founder of Biomedtrics Inc., a diabetes data management company where he raised funding and commercialized a mobile medical data device. Prior to that he was COO of Pelikan Technologies, a Point of Care glucose testing company.
Earlier in his career Bob held multiple senior roles at Abbott Laboratories, including Business Unit Manager for Thyroid, Metabolic and Cardiovascular Diseases, Technical Support Director and Director of Operations. Bob has worked and lived in the U.S., Europe and Asia.
In his various career roles, he has been responsible for the R&D, engineering, manufacturing and launch of numerous products across a spectrum of technologies including IVD immunoassays, Point of Care and digital health wireless devices.
Bob received a Bachelor of Science Degree in Biology from the University of Illinois Urbana-Champaign.